In this study of 29-month-old male Fischer and Sprague-Dawley rats, the tumor pheochromocytoma occurred in seven of 20 Fischer rats (35%) and ten of 22 Sprague-Dawley rats (45%). Mean blood pressures and mean urinary vanillylmandelic acid levels of rats with pheochromocytomas did not vary significantly from rats with no tumors. Pheochromocytoma in our rats generally was non-functional or of minimal clinical significance. The content of chromafin granules . in tumor cells varied from abundant to not detectable, thus it was apparent that the absence of detectable chromafin granules does not eliminate the diagnosis of pheochromocytoma.
The most frequent rat adrenal medullary tumors generally are considered to be pheochromocytomas. Until recently the absence of obvious clinical signs and the difference in tumor cell morphology between the small dark pheochromocyte which comprises the bulk of rat adrenal medullary tumors and the large, opennucleated cell with abundant pale frothy cytoplasm which comprises the tumor in man and other mammals led investigators to apply a specific name to such rat tumors. This designation, medullary a d e n~m a ,~. ' now is seldom encountered and the term pheochromocytoma is preferred. Non-neoplastic medullary cell proliferation is designated hyperplasia but the distinction is arbitrary.
Our experience with rats having pheochromocytomas has been that the tumors rarely are detected from clinical signs. The diagnosis invariably is made only at necropsy, or more frequently, microscopically. Additionally, we have been puzzled by the fact that the cells of these tumors are chromafin-positive and contain catecholamine granules when examined with the electron microscope ( fig. 1 ), yet histochemical staining demonstrates no significant quantities of norepinephrine or epinephrine. The presence of functional catecholamine-secreting tumors in research animals could have a significant impact upon physiologic and metabolic determinations. Additionally, because of the unusual appearance of these tumor cells in rats, the absence of readily detectable clinical signs from a tumor which should be functionally active, and the histochemical incongruities, we believed it necessary to determine whether the functions associated with catecholamines could be detected in tumor-bearing animals.
Materials and Methods
Two strains of rats, Fischer 344 and Sprague-Dawley, were obtained at six weeks of age (Charles River Company, Portage, MI). The study involved male rats housed individually in hanging stainless steel cages with wire bottoms. Rats were provided Certified Rodent Chow 5002" (Ralston Purina Company, St. Louis, MO) ad libitum and drinking water was available from individual automatic watering devices. The study was terminated when the rats were 29 months of age. At that time there were 20 surviving Fischer rats and 22 surviving Sprague-Dawley rats.
Blood pressure determinations were done on these 42 rats by two separate individuals three times during the two weeks preceding sacrifice. Determinations were made using the Arteriosonde 1022 ultrasonic Doppler system (Kontron Cardiovascular, Inc., Everett, MA) with direct digital read-out of systolic values in millimeters of mercury. This procedure involves use of a tail cuff containing an ultrasound transducer placed immediately beneath the ventral coccygeal artery. The rats were not anesthetized but were restrained in hollow plastic tubes made from discarded uncapped laboratory bottles with the bottoms removed. The values presented represent the means of the three determinations on each rat.
Urine was collected the week prior to sacrifice by housing the rats individually for 18 hours in stainless steel metabolism cages. No food and water were provided during this collection period. Urine was collected into ampules containing 1.2 ml of 6 molar hydrochloric acid. The acidity was readjusted after collection to pH' using hydrochloric acid. All samples were stored at -40°C for approximately one month prior to analysis. Urinary 3-methoxy-4-hydroxymandelic acid (vanillylmandelic acid) determinations were made using the method (aroma .03
of Pisano.'' The previously acidified urine samples were extracted with ethyl acetate. Potassium carbonate solution was used to extract the phenolic acids from the ethyl acetate. The potassium carbonate solution was treated with sodium metaperiodate at 50°C to oxidize vanillylmandelic acid to vanillin. The latter was extracted selectively from the reaction mixture using toluene. Vanillin concentration was determined spectrophotometrically at 360 nm using a Carey model 219 scanning spectrophotometer (Varian, Palo Alto, CA). Optical density readings were corrected for contaminants by subtracting the readings of an unoxidized urine blank for each rat. The optical densities were compared to a standard curve of varying vanillin concentrations in order to quantitate the levels of vanillylmandelic acid originally present in the urine samples. Duplicate analyses were done for each urine sample. Rats were anesthetized in a desiccator jar containing chloroform, exsanguinated under cold flowing tap water, and necropsied immediately. Adrenals were removed and placed intact into Millonigs (pH 7.2) buffered 5% glutaraldehyde containing 2.5% potassium dichromate and 1% sodium sulfate. They were fixed for two days, bisected, and one half was placed in 80% ethanol for later electron microscopy. The other halfwas processed, embedded in parafin, and sectioned at 6 pm. Adjacent paired sections were stained with hematoxylin and eosin or using the glutaraldehyde-toluidine blue technique4 for epinephrine and norepinephrine. Adrenals examined ultrastructurally were embedded in araldite resin,'" sectioned using an LKB Nova ultramicrotome (PMV AB, Stockholm), stained wtih uranyl acetate and lead citrate and examined with a Zeiss model 109 electron microscope (Carl Zeiss, Oberkochen, Wuerttemberg, W. Germany).
Proliferative adrenal medullary lesions were classified as either hyperplasia or pheochromocytoma or malignant pheochromocytoma by applying the following criteria to dichromate-hematoxylin-eosin stained sections.
H-vperplasia: cells uniform in appearance; nuclei dark, uniformly round, no mitotic figures; cytoplasm darkly eosinophilic and compressed; nodules single or multiple but with irregular poorly demarcated borders blending imperceptibly into adjacent medulla or cortex; no compression of adjacent tissue. Pheochromocytoma: cells same general appearance as with hyperplasia but with variation in size and shape of both the nucleus and the total cell; single or not more than two nodules; borders of nodules well defined; compression of adjacent tissue; occasional mitotic figures; nodules may or may not be larger than hyperplastic foci.
Malignant Pheochromocyroma: great nuclear and cytoplasmic variation; many nuclei enlarged and lobed; mitoses common; hemorrhage and necrosis common; same size or larger than pheochromocytoma; invasion of capsule, vessels, adjacent lymph node, kidney, or distant metastasis.
Blood pressure and vanillylmandelic acid values were analyzed statistically as non-parametric data using the Mann-Whitney method,' and as parametric data using regression analysis.' All were one-sided tests.
Results
The number of proliferative adrenal medullary lesions was surprisingly high, occumng in 1 1 of 20 Fischer rats and 13 of 22 Sprague-Dawley rats. If only lesions classified as tumors are considered; then seven (35%) of the Fischer and ten (45%) of the Sprague-Dawley rats were affected.
The presence of chromafin granules was required initially for any of the three diagnoses, however, it soon was apparent that occasional tumors or clusters of cells within tumors had few or no granules. The requirement therefore was considered inappropriate. The distribution of blood pressure and vanillylmandelic acid values when compared with the occurrence of proliferative lesions is given in tables I and 11. A summary tabulation for these values for each strain and for the two strains combined is given in table 111.
The blood pressure values for Fischer rats with proliferative adrenal medullary lesions (hyperplasia or pheochromocytoma) were compared statistically with values in rats lacking such lesions. The differences were not significant when subjected to analysis using either the Mann-Whitney or regression analysis methods (table IV). Mere scanning of the mean values (table 111) makes the lack of meaningful difference between groups obvious. The highest value obtained (rat 59, table I) was from a rat with microscopically normal adrenals.
A similar lack of significant variation is seen when vanillylmandelic acid levels from Fischer rats are examined. No individual values were increased noticeably (table I), and the two lowest values were found in rats with pheochromocytoma and with hyperplasia.
Similar lack of significant increases of blood pressure or urinary vanillylmandelic acid were found in Sprague-Dawley rats with adrenal medullary proliferative lesions (table 11) . A moderate increase in blood pressure (149 mm, rat 60) occurred in a single rat with pheochromocytoma, and the only marked increase in vanillyl-mandelic acid levels occurred in a single rat with hyperplasia (table 11, rat 54). This latter rat was responsible for the higher mean values of vanillylmandelic acid in Sprague-Dawley rats with hyperplasia when compared with rats with no proliferative change and rats with pheochromocytoma (table 111) .
If strain differences are disregarded and all rats are considered as a common population (table III) , it is evident that significant increases in blood pressure or urinary vanillylmandelic acid levels generally do not accompany adrenal medullary proliferative lesions.
Discussion
If an increase in catecholamine production is characteristic of adrenal medullary cell proliferation, the arbitrarily designated "hyperplastic" as well as neoplastic lesions should be included in any statistical analysis of function. The distinction between hyperplastic and neoplastic adrenal medullary lesions may be an artificial histologic contrivance. The hyperplastic changes probably preceded neoplastic changes frequently. For the$e reasons statistical analysis was done using rats with hyperplasia, pheochromocytoma, and malignant pheochromocytoma as a single group with which normal rats were compared.
Systolic blood pressure elevations in man with pheochromocytoma may reach 200 or 300 mm Hg during Such effects are erratic and may depend upon physiologic or mechanical stimulation of the neoplastic gland; nevertheless some increases would be expected in such a large group of tumor-bearing rats. None of the values presented here represent such massive shifts.
It is puzzling that these tumors contain chromafinpositive granules, and at least one commonly used rat pheochromocytoma (PC-1 2), when originally propagated in culture and transmitted, produced local invasion, elevated blood pressure and urinary vanillylmandelic acid, and death." Also, in our experience these tumors contain electron-microscopically visible granules indistinguishable from catecholamine granules. Yet, when tumors are examined histochemically, they contain only small amounts of norepinephrine and no epinephrine.
The cells comprising the majority of these tumors are smaller and darker than the more common medullary pheochromocytes of normal rats. They probably represent the previously described small dark granule cells.' Recently it has been shown that these cells produce d~p a m i n e .~ If this is correct and these comprise the cells of tumor origin, the presence of dopamine would account for the absence of blood pressure increases or other obvious clinical signs. One still would expect increases in urinary catecholamine metabolites such as vanillylmandelic acid, however.
Tumors, which were unquestionably pheochromocytomas-judged by location and cellular morphology-contained various quantities of chromafin-positive granules. The quantities varied from tumor to tumor and were abundant to non-detectable. This is bff, and Houser Table IV expected since non-functional tumors occur in various endocrine organs of man and animals. It does suggest, however, that the presence of demonstrable chromafin granules is not an essential for the diagnosis of pheochromocytomas.
